Finance & markets · 19/10/2026

Ultima Genomics Selected for Landmark Large-Scale Immune Profiling Study with IMU Biosciences, UK Biobank and Waters Corporation

Ultima Genomics has been chosen to support a groundbreaking large-scale immune profiling study involving IMU Biosciences, UK Biobank, and Waters Corporation, utilizing Ultima Genomics' UG200 Sequencing Platform to analyze 80,000 blood samples from UK Biobank participants.